Blood cancers

Excellent outcomes seen for Burkitt lymphoma

Adult patients with advanced Burkitt lymphoma have excellent outcomes with intensive immunochemotherapy protocols, according to findings from a large real-word observational study. Data for 264 adults derived from lymphoma registries in six countries showed that most had early normalisation of survival and minimal risk of relapse when treated with rituximab containing dose-intenseĀ  chemotherapy protocols. The ...

Already a member?

Login to keep reading.

© 2021 the limbic